Stewart-Treves syndrome: pathogenesis and management.
Identifieur interne : 001E11 ( PubMed/Checkpoint ); précédent : 001E10; suivant : 001E12Stewart-Treves syndrome: pathogenesis and management.
Auteurs : Amit Sharma [États-Unis] ; Robert A. SchwartzSource :
- Journal of the American Academy of Dermatology [ 1097-6787 ] ; 2012.
Descripteurs français
- KwdFr :
- MESH :
- diagnostic : Hémangiosarcome, Lymphangiosarcome.
- physiopathologie : Hémangiosarcome, Lymphangiosarcome.
- étiologie : Hémangiosarcome, Lymphangiosarcome.
- Diagnostic différentiel, Humains.
English descriptors
- KwdEn :
- MESH :
- diagnosis : Hemangiosarcoma, Lymphangiosarcoma.
- etiology : Hemangiosarcoma, Lymphangiosarcoma.
- physiopathology : Hemangiosarcoma, Lymphangiosarcoma.
- Diagnosis, Differential, Humans.
Abstract
Stewart-Treves syndrome is a malignancy that arises within chronic lymphedema. Although classically described as a consequence of radical mastectomy, this lymphangiosarcoma has been documented to occur in cases of congenital and other causes of chronic secondary lymphedema. The development of this aggressive lymphangiosarcoma at sites of chronic lymphedema renders it a possible model for Kaposi sarcoma. Because of the increase in conservative treatment for breast carcinoma and improvement of operative and radiation therapy techniques, the prevalence of Stewart-Treves syndrome has decreased. Regardless, this malignancy significantly worsens patients' outcomes and needs to be diagnosed and treated early. Chemotherapy and radiation therapy have not improved survivorship significantly. Early amputation or wide local excision offers the best chance for long-term survival. Yet, overall prognosis remains dismal. Untreated patients usually live 5 to 8 months after diagnosis.
DOI: 10.1016/j.jaad.2012.04.028
PubMed: 22682884
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:22682884Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Stewart-Treves syndrome: pathogenesis and management.</title>
<author><name sortKey="Sharma, Amit" sort="Sharma, Amit" uniqKey="Sharma A" first="Amit" last="Sharma">Amit Sharma</name>
<affiliation wicri:level="1"><nlm:affiliation>Dermatology and Pathology, New Jersey Medical School, Newark, New Jersey 07103-2714, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Dermatology and Pathology, New Jersey Medical School, Newark, New Jersey 07103-2714</wicri:regionArea>
<wicri:noRegion>New Jersey 07103-2714</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Schwartz, Robert A" sort="Schwartz, Robert A" uniqKey="Schwartz R" first="Robert A" last="Schwartz">Robert A. Schwartz</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:22682884</idno>
<idno type="pmid">22682884</idno>
<idno type="doi">10.1016/j.jaad.2012.04.028</idno>
<idno type="wicri:Area/PubMed/Corpus">002089</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002089</idno>
<idno type="wicri:Area/PubMed/Curation">002089</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002089</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002089</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002089</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Stewart-Treves syndrome: pathogenesis and management.</title>
<author><name sortKey="Sharma, Amit" sort="Sharma, Amit" uniqKey="Sharma A" first="Amit" last="Sharma">Amit Sharma</name>
<affiliation wicri:level="1"><nlm:affiliation>Dermatology and Pathology, New Jersey Medical School, Newark, New Jersey 07103-2714, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Dermatology and Pathology, New Jersey Medical School, Newark, New Jersey 07103-2714</wicri:regionArea>
<wicri:noRegion>New Jersey 07103-2714</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Schwartz, Robert A" sort="Schwartz, Robert A" uniqKey="Schwartz R" first="Robert A" last="Schwartz">Robert A. Schwartz</name>
</author>
</analytic>
<series><title level="j">Journal of the American Academy of Dermatology</title>
<idno type="eISSN">1097-6787</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Diagnosis, Differential</term>
<term>Hemangiosarcoma (diagnosis)</term>
<term>Hemangiosarcoma (etiology)</term>
<term>Hemangiosarcoma (physiopathology)</term>
<term>Humans</term>
<term>Lymphangiosarcoma (diagnosis)</term>
<term>Lymphangiosarcoma (etiology)</term>
<term>Lymphangiosarcoma (physiopathology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Diagnostic différentiel</term>
<term>Humains</term>
<term>Hémangiosarcome (diagnostic)</term>
<term>Hémangiosarcome (physiopathologie)</term>
<term>Hémangiosarcome (étiologie)</term>
<term>Lymphangiosarcome (diagnostic)</term>
<term>Lymphangiosarcome (physiopathologie)</term>
<term>Lymphangiosarcome (étiologie)</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Hemangiosarcoma</term>
<term>Lymphangiosarcoma</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Hémangiosarcome</term>
<term>Lymphangiosarcome</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Hemangiosarcoma</term>
<term>Lymphangiosarcoma</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Hémangiosarcome</term>
<term>Lymphangiosarcome</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Hemangiosarcoma</term>
<term>Lymphangiosarcoma</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Hémangiosarcome</term>
<term>Lymphangiosarcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Diagnosis, Differential</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Diagnostic différentiel</term>
<term>Humains</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Stewart-Treves syndrome is a malignancy that arises within chronic lymphedema. Although classically described as a consequence of radical mastectomy, this lymphangiosarcoma has been documented to occur in cases of congenital and other causes of chronic secondary lymphedema. The development of this aggressive lymphangiosarcoma at sites of chronic lymphedema renders it a possible model for Kaposi sarcoma. Because of the increase in conservative treatment for breast carcinoma and improvement of operative and radiation therapy techniques, the prevalence of Stewart-Treves syndrome has decreased. Regardless, this malignancy significantly worsens patients' outcomes and needs to be diagnosed and treated early. Chemotherapy and radiation therapy have not improved survivorship significantly. Early amputation or wide local excision offers the best chance for long-term survival. Yet, overall prognosis remains dismal. Untreated patients usually live 5 to 8 months after diagnosis.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22682884</PMID>
<DateCreated><Year>2012</Year>
<Month>11</Month>
<Day>19</Day>
</DateCreated>
<DateCompleted><Year>2013</Year>
<Month>01</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised><Year>2012</Year>
<Month>11</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6787</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>67</Volume>
<Issue>6</Issue>
<PubDate><Year>2012</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of the American Academy of Dermatology</Title>
<ISOAbbreviation>J. Am. Acad. Dermatol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Stewart-Treves syndrome: pathogenesis and management.</ArticleTitle>
<Pagination><MedlinePgn>1342-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaad.2012.04.028</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0190-9622(12)00451-3</ELocationID>
<Abstract><AbstractText>Stewart-Treves syndrome is a malignancy that arises within chronic lymphedema. Although classically described as a consequence of radical mastectomy, this lymphangiosarcoma has been documented to occur in cases of congenital and other causes of chronic secondary lymphedema. The development of this aggressive lymphangiosarcoma at sites of chronic lymphedema renders it a possible model for Kaposi sarcoma. Because of the increase in conservative treatment for breast carcinoma and improvement of operative and radiation therapy techniques, the prevalence of Stewart-Treves syndrome has decreased. Regardless, this malignancy significantly worsens patients' outcomes and needs to be diagnosed and treated early. Chemotherapy and radiation therapy have not improved survivorship significantly. Early amputation or wide local excision offers the best chance for long-term survival. Yet, overall prognosis remains dismal. Untreated patients usually live 5 to 8 months after diagnosis.</AbstractText>
<CopyrightInformation>Copyright © 2012 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sharma</LastName>
<ForeName>Amit</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Dermatology and Pathology, New Jersey Medical School, Newark, New Jersey 07103-2714, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Schwartz</LastName>
<ForeName>Robert A</ForeName>
<Initials>RA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2012</Year>
<Month>06</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Am Acad Dermatol</MedlineTA>
<NlmUniqueID>7907132</NlmUniqueID>
<ISSNLinking>0190-9622</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList><SupplMeshName Type="Disease" UI="C537491">Stewart Treves syndrome</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006394" MajorTopicYN="Y">Hemangiosarcoma</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008204" MajorTopicYN="Y">Lymphangiosarcoma</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year>
<Month>07</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2012</Year>
<Month>04</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2012</Year>
<Month>04</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2012</Year>
<Month>6</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2012</Year>
<Month>6</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2013</Year>
<Month>1</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">22682884</ArticleId>
<ArticleId IdType="pii">S0190-9622(12)00451-3</ArticleId>
<ArticleId IdType="doi">10.1016/j.jaad.2012.04.028</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
</list>
<tree><noCountry><name sortKey="Schwartz, Robert A" sort="Schwartz, Robert A" uniqKey="Schwartz R" first="Robert A" last="Schwartz">Robert A. Schwartz</name>
</noCountry>
<country name="États-Unis"><noRegion><name sortKey="Sharma, Amit" sort="Sharma, Amit" uniqKey="Sharma A" first="Amit" last="Sharma">Amit Sharma</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E11 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001E11 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:22682884 |texte= Stewart-Treves syndrome: pathogenesis and management. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:22682884" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |